AnGes (STU:AJW) Common Stock: €220.35 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:AJW AnGes Inc STU:AJW
43 GF Score
Price €0.27
GF Value €0.52
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is AnGes Common Stock?

AnGes STU:AJW +3.88% 43 Common Stock is €220.35 Mil as of Dec. 2025. GuruFocus rates STU:AJW with a GF Score™ of 43/100 and a GF Value™ of €0.52 (Possible Value Trap). The stock has 5 warning signs investors should review.

AnGes's quarterly common stock declined from Jun. 2025 (€234.94 Mil) to Sep. 2025 (€231.28 Mil) and declined from Sep. 2025 (€231.28 Mil) to Dec. 2025 (€220.35 Mil).

AnGes's annual common stock increased from Dec. 2023 (€223.25 Mil) to Dec. 2024 (€231.31 Mil) but then declined from Dec. 2024 (€231.31 Mil) to Dec. 2025 (€220.35 Mil).


AnGes Common Stock Historical Data

* Premium members only.

The historical data trend for AnGes's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AnGes Common Stock Chart

AnGes Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 259.36 245.92 223.25 231.31 220.35

AnGes Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 238.43 234.94 231.28 220.35 220.44
STU:AJW
43GF Score
AnGes Inc STU:AJW
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AnGes Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €220.35 Mil mean?
AnGes (STU:AJW) has a Common Stock of €220.35 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on AnGes and its competitors.
Is AnGes' Common Stock too high?
AnGes' current Common Stock is €220.35 Mil. Overall, AnGes has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AnGes' Common Stock compare to VRTX and REGN?
AnGes' Common Stock of €220.35 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on AnGes and its competitors. AnGes's current Common Stock is €220.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AnGes stock overvalued right now?
Based on GuruFocus' analysis, AnGes (STU:AJW) is currently considered Possible Value Trap. The stock's GF Value™ is €0.52, compared to a current price of €0.27 — trading 48.5% below its estimated fair value. The current Common Stock is €220.35 Mil. AnGes' overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For AnGes (STU:AJW), the current Common Stock is €220.35 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AnGes (STU:AJW) Overvalued in 2026?

Based on GuruFocus' analysis, AnGes stock appears to be undervalued. The current stock price of €0.27 is trading 48.5% below its estimated GF Value™ of €0.52. GuruFocus considers AnGes to be Possible Value Trap.

Key valuation signals for STU:AJW:

  • Common Stock: €220.35 Mil
  • GF Value™: €0.52 vs. price of €0.27 (48.5% below fair value)
  • GF Score™: 43/100 with 5 warning signs

No single metric tells the full story. See the STU:AJW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AnGes Business Description

Other Exchanges 4563:Japan
Address 7-7-15, Saito-asagi, 4F, Saito Bio-Incubator, Ibaraki, Osaka, JPN, 567-0085
AnGes Inc is a biopharmaceutical company. The company is involved in research and development and sales of pharmaceuticals such as gene-based drugs (gene therapy products, nucleic acid drugs); contract testing for rare genetic diseases, etc.
43GF Score

Get the complete analysis for STU:AJW

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.27
Price
€0.52
GF Value